Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
Madison Square Garden Sports (MSGS) has caught investor attention after a sharp share price move, with the stock showing a 31.3% gain over the past 3 months and 7.1% over the past month.
See our latest analysis for Madison Square Garden Sports.
That recent 31.3% 3 month share price return and 20.6% year to date share price return comes on top of a 65.2% 1 year total shareholder return, which suggests momentum has been building rather than fading.
If MSGS’s jump has you thinking more broadly about sports and entertainment exposure, it might be a good time to see what else is moving with our 19 top founder-led companies.
With MSGS trading at $312.18 against an analyst price target of $348.60 and an indicated intrinsic premium of about 15%, you have to ask whether there is still value on the table or whether the market is already pricing in future growth.
At a last close of $312.18 versus a narrative fair value of about $311.50, this widely followed view effectively treats MSGS as fully valued and slightly stretched.
The upcoming ramp-up in high-value national media rights fees for the NBA (beginning in fiscal ’26) will offset the recent step-down in local media rights, positioning MSG Sports for an overall increase in recurring media revenue and supporting both revenue growth and higher net margins over the next several years.
Read the complete narrative.
Curious how modest top line growth, changing media contracts and a richer future earnings multiple all fit together? The full narrative spells out the cash flow path behind that fair value call.
Result: Fair Value of $311.50 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, there are still watchpoints, including reduced local media rights fees and rising player and tax costs, which could pressure margins and challenge the current narrative.
Find out about the key risks to this Madison Square Garden Sports narrative.
If the mix of momentum and fair value talk feels split, do not wait too long to check the facts and shape your own view with 3 important warning signs.
If MSGS has sharpened your focus, do not stop here. The screener can surface other stocks that fit your style before the crowd catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MSGS.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Comments are closed.